VEON Ltd ADRVEON
Price$73.93Intrinsic value$106.9445% above price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $4.4B+9.9% YoYTTM through 31 Dec 2025
Net Income $591M+21.4% YoYTTM through 31 Dec 2025
Free Cash Flow $1.7BTTM through 31 Dec 2025

Margins

Current
Gross Margin88.0%
EBITDA Margin45.9%
Operating Margin32.7%
Net Margin13.4%

Returns

36.7%ROE
5.8%ROA
19.4%ROIC

Balance Sheet Health

Debt / Equity3.00x
Current Ratio0.91x
Net Debt$3.2B
Cash & Equivalents$1.7B

Quality Metrics

Piotroski F-Score6 / 9
FCF Margin38.9%
Rule of 4054.1
Earnings-Beat Rate50.0%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $4.4B
Diluted EPS
'19'20'21'22'23'24'25
FY2025: $0.34

Dividend

$3.75Per share, FY20200.00%Yield

Capital Allocation

Capex Intensity16.7%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.